With increase of maternal age, the incidence of haematological malignancies during
pregnancy is rising and posing diagnostic and treatment challenges. Lymphoma is the fourth …

The reported higher risk of maternal and fetal complications in women with
myeloproliferative neoplasms (MPN) poses challenge during pregnancy. A national …

Hemopoietic neoplasias are unique cancers generally affecting bone marrow, and requires
a special attention for disease control and also their complications. When these neoplastic …

Objective: Detailed analyses of clinical characteristics of myocardial infarction (MI) as an
essential thrombocythemia (ET)-and polycythemia vera (PV)-related complication have …

Controversies still exist regarding definition of the thrombotic risks in Ph‐(BCR/ABL 1‐)
myeloproliferative disorders with thrombocythemia (MPD‐T). Platelet counts at diagnosis are …

Background Anagrelide is an orally active, quinazolone-derived, platelet-lowering agent that
acts by blocking megakaryocyte maturation and polyploidization as well as proplatelet …

In patients with Philadelphia-negative chronic myeloproliferative neoplasms (MPNs), the anti-
thrombotic and/or cytoreductive treatment in the follow-up may affect the evaluation of the …

The current consensus on the diagnosis, prognosis, and treatment of essential
thrombocythemia (ET) is based on experts' recommendations. However, several aspects of …

Chronic myeloproliferative neoplasms are a group of disorders characterized by clonal
disturbance of pluripotent bone marrow stem cells, leading to an excessive increase in …

Introduction. A high platelet count, or thrombocytosis, is either a reactive process or a result
of a myeloproliferative disorder. Ankylosing spondylitis is a chronic inflammatory rheumatic …